Stay updated with breaking news from California Based Nutcracker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ARCH Venture Partners led the Series C round of financing for Nutcracker Therapeutics, a company developing new RNA drugs. The company’s process for developing and manufacturing RNA therapies borrows from techniques used in the technology sector.
Close icon Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification. Bruno Cassaro de Andrade, a chemical engineering student, works with a test separating specific proteins to be applied in the production of coronavirus vaccines on March 24, 2020 in Belo Horizonte, Brazil. Pedro Vilela/Getty Images The pandemic has forced VCs to confront the large-scale impact of infectious disease. Evolving virus variants have made major firms like Andreessen Horowitz rethink the value of investing in ...